Mucus in nose and throat: How to stop post-nasal drip at home
Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...
7 Ways to Stop Post-Nasal Drip, According to Doctors
Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
来自MSN19 天
What Is Mouth Taping and Should You Try It?
Mouth taping offers sleep benefits but has some potential risks. Learn how to mouth-tape safely and other options to reduce snoring, dry mouth and bad breath.
India Today21 天
US FDA approves new nasal spray for depression treatment: All about it
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
healthday21 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
The Daily Beast21 天
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report21 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
Newsweek21 天
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
New York Post21 天
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
CNN22 天
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Fast Company22 天
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ ...
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Gizmodo22 天
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...